Zobrazeno 1 - 10 of 29 pro vyhledávání: '"Maynard JP"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
P2 purinergic receptor expression and function in tumor-related immune cells.
Autor: Manoharan V; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Adegbayi OO; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Maynard JP; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. maynard@jhmi.edu.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. maynard@jhmi.edu.
Publikováno v: Purinergic signalling [Purinergic Signal] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.
Zobrazit plný text záznamu
5
Akademický článek
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality.
Autor: Arunachalam AR; Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Samuel SS; Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Mani A; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Maynard JP; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Stayer KM; Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Dybbro E; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Narayanan S; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Biswas A; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Pathan S; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Soni K; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Kamal AHM; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States., Ambati CSR; Advanced Technology Core, Baylor College of Medicine, Houston, Texas, United States., Putluri N; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States., Desai MS; Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States., Thevananther S; Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States.
Publikováno v: American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2023 Nov 01; Vol. 325 (5), pp. G471-G491. Date of Electronic Publication: 2023 Sep 12.
Zobrazit plný text záznamu
6
Akademický článek
Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP.
Autor: Bogan RK; University of South Carolina School of Medicine, Columbia, SC, USA. Electronic address: Richard.bogan@bogansleep.com., Maynard JP; CTI Clinical Research Center, Cincinnati, OH, USA. Electronic address: jmaynard@ctifacts.com., Neuwirth R; Takeda Development Center Americas, Inc., Lexington, MA, USA. Electronic address: Rachel.Neuwirth@takeda.com., Faessel H; Takeda Development Center Americas, Inc., Lexington, MA, USA. Electronic address: helene.faessel@takeda.com., Swick T; Takeda Development Center Americas, Inc., Lexington, MA, USA. Electronic address: todd.swick@takeda.com., Olsson T; Takeda Development Center Americas, Inc., Lexington, MA, USA. Electronic address: tina.olsson@takeda.com.
Publikováno v: Sleep medicine [Sleep Med] 2023 Jul; Vol. 107, pp. 229-235. Date of Electronic Publication: 2023 May 11.
Zobrazit plný text záznamu
7
Akademický článek
Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Autor: Schweitzer PK; Sleep Medicine and Research Center, St. Luke's Hospital, 232 South Woods Mill Road, Chesterfield, MO, 63017, USA. paula.schweitzer@stlukes-stl.com., Maynard JP; CTI Clinical Trial and Consulting, Cincinnati, OH, USA., Wylie PE; Arkansas Center of Sleep Medicine, Little Rock, AR, USA., Emsellem HA; The Center for Sleep & Wake Disorders, Chevy Chase, MD, and Department of Neurology (Clinical Faculty), George Washington University Medical Center, Washington, DC, USA., Sands SA; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Publikováno v: Sleep & breathing = Schlaf & Atmung [Sleep Breath] 2023 May; Vol. 27 (2), pp. 495-503. Date of Electronic Publication: 2022 May 13.
Zobrazit plný text záznamu
8
Akademický článek
Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.
Autor: Maynard JP; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Godwin TN; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lu J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Vidal I; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lotan TL; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., De Marzo AM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Joshu CE; Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Sfanos KS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publikováno v: The Prostate [Prostate] 2022 Dec; Vol. 82 (16), pp. 1505-1519. Date of Electronic Publication: 2022 Aug 16.
Zobrazit plný text záznamu
9
Akademický článek
P2 purinergic receptor dysregulation in urologic disease.
Autor: Maynard JP; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. maynard@jhmi.edu.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA. maynard@jhmi.edu., Sfanos KS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publikováno v: Purinergic signalling [Purinergic Signal] 2022 Sep; Vol. 18 (3), pp. 267-287. Date of Electronic Publication: 2022 Jun 10.
Zobrazit plný text záznamu
10
Akademický článek
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.
Autor: Mendes AA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Lu J; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland., Kaur HB; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Zheng SL; Program for Personalized Cancer Care, NorthShore University Health System, Evanston, Illinois., Xu J; Program for Personalized Cancer Care, NorthShore University Health System, Evanston, Illinois., Hicks J; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Weiner AB; Department of Urology, Northwestern University, Chicago, Illinois., Schaeffer EM; Department of Urology, Northwestern University, Chicago, Illinois.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Ross AE; Department of Urology, Northwestern University, Chicago, Illinois.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Balk SP; Department of Medicine and Cancer Center, Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Taplin ME; Dana-Farber Cancer Institute, Boston, Massachusetts., Lack NA; School of Medicine, Koc University, Istanbul, Turkey.; Koc University Research Center for Translational Medicine, Koc University, Istanbul, Turkey.; Vancouver Prostate Center, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Tekoglu E; School of Medicine, Koc University, Istanbul, Turkey., Maynard JP; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., De Marzo AM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Antonarakis ES; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Sfanos KS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Joshu CE; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland., Shenderov E; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Lotan TL; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Publikováno v: Cancer [Cancer] 2022 Jun 15; Vol. 128 (12), pp. 2269-2280. Date of Electronic Publication: 2022 Mar 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje